Search Thermo Fisher Scientific
- Contáctenos
- Orden Rápida
-
¿No tiene una cuenta? Crear una cuenta
Search Thermo Fisher Scientific
Real-time PCR kits for the qualitative and quantitative detection of HBV and HCV in serum and plasma
Hepatitis is defined as inflammation of the liver and can be caused by infectious viruses. Viral hepatitis can be caused by the hepatitis A, B, C, D and E virus (HAV, HBV, HCV, HDV and HEV, respectively), but only HBV and HCV can develop into chronic infections (1). Individuals with chronic HBV or HCV infection may have increased risk of complications, such as liver cirrhosis and cancer (1). Globally, over 350 million people are living with chronic HBV or HCV infection and the viruses cause over 1 million death per year (1,2). Accurate and reliable diagnosis of the virus is important to guide patient management (3,4).
The CE-marked Applied Biosystems TaqPath™ Menu Hepatitis B Virus (HBV) and Hepatitis C Virus PCR Kits are designed to deliver reliable qualitative and quantitative diagnostic results with excellent sensitivity and specificity. This offers confidence in diagnostic and treatment decisions and can help mitigate the spread of these infections.
Want to use our solutions? Contact us for details on our limited time offer. |
Reliable diagnostics*
Easy-to-use concept*
Contamination reduction*
WHO standard–based quantification (need to add reference)
Compatible with a wide range of real-time PCR devices
CE-IVD marked kit
Reliable diagnostics*
Easy-to-use concept*
Contamination reduction*
WHO standard–based quantification (need to add reference)
Compatible with a wide range of real-time PCR devices
CE-IVD marked kit
*Refer to the Instructions for Use (IFU)
References:
1. World Health Organization. (2023). Hepatitis. World Health Organization.
2. European Centre for Disease Prevention and Control. (2022, December 14). Prevention of hepatitis B and C in the EU/EEA. European Centre for Disease Prevention and Control.
3. World Health Organization. (2022, June 24). Hepatitis B. World Health Organization.
4. World Health Organization. (2022, June 24). Hepatitis C. World Health Organization.
For In Vitro Diagnostic Use. Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU). Product availability by country varies. For product availability in your country, check the associated product webpages. TaqPath Menu | GeneProof assays are manufactured by GeneProof and distributed by Thermo Fisher Scientific. GeneProof is a registered mark of GeneProof a.s. © 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.